Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy. HPB (Oxford) 2006;8(5):365-8
Date
03/12/2008
Pubmed ID
18333089Pubmed Central ID
PMC2020747DOI
10.1080/13651820600804005Scopus ID
2-s2.0-33749161234 (requires institutional sign-in at Scopus site)
25 CitationsAuthor List
Evans DB, Multidisciplinary Pancreatic Cancer Study Group
Author
Douglas B. Evans MD Chair, Professor in the Surgery department at Medical College of Wisconsin